Clinical trial
Switch Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease
NCT02231255 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Switch Post Marketing Surveillance Study in Patients With Idiopathic Parkinson's Disease
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- Not reported
- Enrollment
- 1,216 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.